PIN Pharma

Developing novel therapies to fight breast and colon cancer.


Financing from the Partnership Fund supports the commercialization of PIN Pharma’s science in New York, further positioning the city as a leader in life sciences.


Early-stage, bio-pharmaceutical company that develops immuno-therapeutic drugs targeted at breast and colon cancer.

Visit site